e-learning
resources
Glasgow 2004
Sunday 05.09.2004
Community acquired pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Are severity scores for community acquired pneumonia being used in secondary care and its impact on appropriateness of antibiotic therapy - a retrospective study
D. Park, H. Moudgil, T. Tjiu, K. S. Srinivasan (Telford, United Kingdom)
Source:
Annual Congress 2004 - Community acquired pneumonia
Session:
Community acquired pneumonia
Session type:
Thematic Poster Session
Number:
1187
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Park, H. Moudgil, T. Tjiu, K. S. Srinivasan (Telford, United Kingdom). Are severity scores for community acquired pneumonia being used in secondary care and its impact on appropriateness of antibiotic therapy - a retrospective study. Eur Respir J 2004; 24: Suppl. 48, 1187
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Long-term impact of DRIP score on antibiotic stewardship in patients with community acquired pneumonia
Source: Virtual Congress 2021 – Pneumonia
Year: 2021
The impact of adherence to guidelines for hospitalized community-acquired pneumonia on health outcomes and mortality: A retrospective cohort study
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Effect of a quality improvement plan on the outcome of patients with community acquired pneumonia
Source: Eur Respir J 2003; 22: Suppl. 45, 545s
Year: 2003
Outpatient management of community acquired pneumonia using severity prediction tools: A systematic review and meta-analysis
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010
Using the ADO score in primary care to target pulmonary rehabilitation to patients at high risk of hospital admission
Source: International Congress 2016 – Management of asthma and COPD in primary care
Year: 2016
The impact of a stewardship programme on outcomes in patients admitted with community-acquired pneumonia
Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections
Year: 2020
Does hospitalization influence tuberculosis’ treatment outcome? – A Portuguese nationwide study
Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Year: 2018
A study of incidence, outcome and antibiotic sensitivity pattern of ventilator associated pneumonia in icu of tertiary care hospital in Nepal
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
Assessment of antibiotic prescribing practises for hospitalised patients with suspected sepsis using a score of "likelihood of infection"
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009
Comparison of prospective scores for predicting mortality and hospital admission in hospitalised patients and out-patients with CAP
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005
Improving outcome in elderly patients with pneumonia
Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI
Year: 2005
A survey of asthma severity, comorbidities and treatments in a paediatric primary care cohort in the UK
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009
Influence on the prognosis of misuse of antibiotics prior to admission in patients with community acquired pneumonia
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010
Effectiveness of empirical treatment of community acquired pneumonia requiring hospitalization
Source: Eur Respir J 2006; 28: Suppl. 50, 166s
Year: 2006
Therapeutic regimens in community acquired pneumonia (CAP): association with patients characteristics and outcomes
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting
Source: Annual Congress 2003 - Epidemiology, therapy and outcome of infections in the ICU
Year: 2003
Influence of statin therapy on clinical symptoms, severity and prognosis in patients with community acquired pneumonia
Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia
Year: 2008
The effects of antibiotic therapy at the pre-hospital stage on the in-hospital mortality in adults with community-acquired pneumonia in Russia: observational study results.
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
The extent of microbiological testing and antibiotic de-escalation in adults with community-acquired pneumonia: a retrospective cohort study.
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018
Costs of treatment of hospitalised community-acquired pneumonia from the hospitals’ perspective – a prospective study comparing moxifloxacin with other antibiotic treatment alternatives
Source: Eur Respir J 2004; 24: Suppl. 48, 185s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept